drugset / Trial / NCT01181063
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers
RandomizedCrossoverOpen-labelTreatment
Summary
Due to the complexity of orally inhaled products (combination of a formulation and a device)and the topical nature of drug delivery to the lung for efficacy in vitro-in vivo correlation(IVIVC) for inhaled dosage forms is not generally known. The rationale of this pilot study is to gain in vivo data of the Budesonide/formoterol EH product variants under development and compare pulmonary deposition (administration with charcoal) of different product variants of Budesonide/formoterol EH with Symbicort TH.
Timeline
- Start
- 2010-08
- Primary completion
- 2010-10
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 320 ug | Inhaled |
| Subject | Budesonide | Small molecule | 400 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 9 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |